U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07917403) titled 'Study NRPT Feasibility in Knee Osteoarthritis' on Oct. 10.
Brief Summary: To Evaluate Feasibility and Exploratory Clinical and Biomarker Signals of NRPT in Adults with Knee Osteoarthritis
Study Start Date: Dec., 2026
Study Type: INTERVENTIONAL
Condition:
Knee Osteoarthristis
Intervention:
DIETARY_SUPPLEMENT: NRPT
EH301 is a higher-dose NRPT supplement containing nicotinamide riboside (NR) and pterostilbene (PT). Each capsule contains 250 mg of nicotinamide riboside and 50 mg of pterostilbene
Recruitment Status: RECRUITING
Sponsor: University of California, San Diego
Information provided by (Responsible Party): Monica Guma, ...